Off-label drugs vs. the merits of centralised regulatory control
Year of publication: |
2008
|
---|---|
Authors: | Boscheck, Ralf |
Published in: |
Intereconomics. - Heidelberg : Springer, ISSN 0020-5346. - Vol. 43.2008, 5, p. 277-281
|
Publisher: |
Heidelberg : Springer |
Subject: | Arzneimittelrecht | Verbraucherschutz | Pharmazeutisches Produkt | Deregulierung | Gesundheitswesen | USA | Deutschland |
-
Off-label drugs vs. the merits of centralised regulatory control
Boscheck, Ralf, (2008)
-
Psychopharmakologisches Enhancement zwischen Konsumentensouveränität und Verbraucherschutz
Schlag, Stefan, (2013)
-
Dangerous Prescribing and Healthcare Fragmentation : Evidence from Opioids
Ericson, Keith M. Marzilli, (2022)
- More ...
-
Internet and consumer privacy: Considering the FTC's do not track proposal
Boscheck, Ralf, (2011)
-
Trade, competition and antidumping: Breaking the impasse!?
Boscheck, Ralf, (2000)
-
Boscheck, Ralf, (2002)
- More ...